[Indications and new developments in pacemaker therapy].

Schweiz Med Wochenschr

Published: November 1986

In the course of the past 25 years the indication for pacemaker implantation has changed from AV-block to the sick sinus syndrome in about 40% of patients. In the same period pacemaker technology has developed considerably and today there are, in addition to the ventricular inhibited pacemaker, two-chamber systems (essentially DDD pacemakers) and pacemakers with an increasing pulse rate during physical effort. The new nomenclature, mode of action and hemodynamic implications of the various systems are explained, and recommendations for implantation are given.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[indications developments
4
pacemaker
4
developments pacemaker
4
pacemaker therapy]
4
therapy] course
4
course years
4
years indication
4
indication pacemaker
4
pacemaker implantation
4
implantation changed
4

Similar Publications

Introduction: Abdominal aortic aneurysms (AAA) are major causes of morbidity and mortality in the elderly population. Endovascular aneurysm repair (EVAR) is associated with lower complications rates than conventional treatment; however, rigorous follow-up with contrast imaging is required to confirm aneurysmal sac exclusion. The main objective of this study was to quantify and evaluate miRNA expression response to EVAR based on serum dosages at the 6-month follow-up.

View Article and Find Full Text PDF

Aim: An end colostomy is a potentially life-saving surgical intervention, but postoperative ostomy management is challenging in resource-limited settings. Socioeconomic, health system, and surgical capacity barriers may delay colostomy reversal. A surgery camp model for addressing the burden of unreversed colostomies has not previously been undertaken in Malawi.

View Article and Find Full Text PDF

Self-care interventions for legal and safe abortions: lessons learned from a woman-centered approach to sexual and reproductive healthcare in Uruguay.

Lancet Reg Health Am

February 2025

Department of Sexual and Reproductive Health and Research, Including the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland.

Problem: In the 1990s, almost 40% of maternal deaths in Uruguay were caused by unsafe abortions.

Approach: A harm reduction model implemented in Uruguay, which addressed the risks associated with unsafe abortion practices by promoting and supporting the self-management of medical abortions by women in their homes, encouraged women's autonomy.

Local Setting: Since 2005, an accelerated decrease in maternal mortality has been recorded in Uruguay, coinciding with the implementation of two major actions: a harm reduction approach with active promotion of self-care through self-management of medical abortions; and in 2012, a change in legislation, which made abortion legal within sexual and reproductive health facilities when requested by women up to 12 weeks of pregnancy or later for specific indications.

View Article and Find Full Text PDF

Revolutionizing ovarian cancer therapy by drug repositioning for accelerated and cost-effective treatments.

Front Oncol

January 2025

Laboratorio de Farmacogenética, UMIEZ, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.

Drug repositioning, the practice of identifying novel applications for existing drugs beyond their originally intended medical indications, stands as a transformative strategy revolutionizing pharmaceutical productivity. In contrast to conventional drug development approaches, this innovative method has proven to be exceptionally effective. This is particularly relevant for cancer therapy, where the demand for groundbreaking treatments continues to grow.

View Article and Find Full Text PDF

Study Design: A retrospective chart review was conducted at a single institution.

Objective: The purpose of this study was to investigate the clinical outcomes of cervical disc arthroplasty (CDA) used for the treatment of symptomatic adjacent segment disease (ASD) developed after anterior cervical discectomy and fusion (ACDF).

Background: A major clinical concern following ACDF is the development of ASD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!